| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |